I85PREP
⌘ K
RPFT study materials
RPFT study resources

Bedside Testing of a Patient with MRSA in a Shared Room

RPFT · Put your knowledge to work in context.

All case studies

Bedside Testing of a Patient with MRSA in a Shared Room

A 58-year-old inpatient with a chronic productive cough and a sputum culture positive for MRSA is ordered for bedside spirometry and DLCO before discharge. He is in a semiprivate room whose other bed is occupied by a transplant patient. During the interview he coughs repeatedly and cannot reliably cover his mouth; he reports that he has been "coughing up a little blood" for two days, which is not in the chart. The laboratory has one portable spirometer with a reusable flow sensor, a supply of combined bacterial/viral filters rated ≥99.9% for particles at the tested size, and no second portable device. The next patient in the laboratory is a 7-year-old with cystic fibrosis, booked in 45 minutes, and the room is also used for exercise testing later that afternoon.

1. Set out your infection-control and safety plan for this visit: what you wear, where and when you test, what equipment you use, and what you do about the cystic fibrosis patient on the schedule.

Read the worked answer

Safety first, before infection control: the hemoptysis. "Coughing up a little blood" for two days is new information that is not in the chart. Hemoptysis is a relative contraindication to forced expiratory maneuvers, and the cause is undetermined. Pause the procedure, notify the covering clinician, and get a decision on whether the study should proceed before any forced effort. This is the single most important step in the scenario - the infection-control question is not the only hazard in the room.

Transmission-based precautions

  • MRSA is transmitted by contact (and by droplets/aerosol generated during coughing and forced maneuvers). Follow the facility's posted precautions for this patient; at minimum, perform hand hygiene before and after, wear gloves and a gown for contact with the patient and equipment, and add a mask plus eye protection given the uncontrolled cough.
  • Ask the ward nurse whether the patient is on contact precautions and what the facility requires; document what you followed.
  • Keep the door closed if the facility requires it, and do not test in a shared room with an immunocompromised roommate present. Move the patient to a single room, a treatment room, or schedule the test as the last of the day - a transplant recipient sharing air with a coughing MRSA patient during forced maneuvers is an unacceptable exposure.

Equipment

  • Use a combined bacterial/viral filter at the patient end, placed so the reusable sensor is protected; treat the filter as contaminated and discard it as biohazardous waste in the room.
  • Use disposable mouthpieces and nose clips; nothing reusable goes back into the carry case without disinfection.
  • Clean and disinfect the exterior of the spirometer and the case after the visit per the manufacturer's contact time.

The cystic fibrosis patient

  • Do not run the CF child on the same device 45 minutes later on a casual wipe-down. Either complete full disinfection with the validated agent and documented contact time plus a filter change and a verification check, or - better - reschedule the child to a later slot with a clean device. CF patients should not be scheduled after a patient with a transmissible respiratory organism; many laboratories have a written rule that CF and transplant patients are seen first or in a separate room. The 45-minute gap is not the issue - the shared sensor and the shared air are.

2. The technologist worries that the filter changes the flow signal and could invalidate the results. How do you handle that, and why does it matter more for this patient than for most?

Read the worked answer

The concern is legitimate. A filter placed in the breathing path adds resistance and dead space, and it can alter the measured flow-volume signal, particularly at high flow and in low-flow regions. The magnitude depends on the filter and the device.

What to do

  1. Follow the manufacturer's stated configuration. If the device was validated with a filter in place, verify and calibrate with that filter type attached - do not verify bare and then test with a filter, or vice versa. The verified configuration must be the tested configuration.
  2. Record it. The log and the patient report should state that the filter was in use, its type, and that verification was performed in that configuration. This is what makes the result defensible.
  3. Recognize the signal of a problem: a sudden change in FEV1/FVC or in the shape of the flow-volume curve after a filter change, or a verification that fails only when the filter is added, means the filter is not compatible with that device.
  4. Account for dead space in small patients. A filter that is negligible for a 70 kg adult can add meaningful dead space for a child or a small adult - this is one reason the pediatric filter must be matched to the device and the patient.

Why it matters more here

  • The filter is not optional for this patient; it is the only thing standing between a reusable sensor and a coughing MRSA patient. You cannot solve the accuracy concern by omitting the filter, so you must solve it by verifying in the filtered configuration.
  • Any bias introduced by the filter will be systematic and repeated, so it will not cancel out; if this patient is being followed serially, the same configuration must be used each time for the numbers to be comparable.
  • And this is a pre-discharge study that may determine home oxygen or follow-up intensity; a result distorted by an unaccounted-for filter is worse than a slightly delayed one.

3. After the visit, the patient coughs directly onto the reusable flow sensor before the filter can be seated. Walk through what happens next, distinguishing cleaning from disinfection, and state what you would do about the afternoon's exercise testing.

Read the worked answer

Sequence of actions

  1. Stop and contain. Do not put the sensor back in the case. Remove it in the room, bag it as contaminated, and perform hand hygiene.
  2. Clean, then disinfect - in that order. Cleaning removes visible organic material (mucus, blood, sputum); disinfection kills or inactivates the organisms that remain. A disinfectant applied to a visibly soiled sensor will fail, because organic material inactivates many disinfectants. So: clean with detergent and water, rinse, dry, then apply the facility's validated disinfectant for the full contact time stated on the label - not a quick wipe-and-rinse.
  3. Record it: which agent, the concentration, the start and stop time, and who did it. Untimed disinfection is indistinguishable from no disinfection when the log is audited.
  4. Do not reuse until dry and, for the device in question, until a verification check confirms it still reads within tolerance. Moisture in a flow sensor is a classic cause of a failed verification - this is why the disinfection step and the QC step are linked.
  5. Notify the supervisor and the ward, because this was an exposure event with a known MRSA source and the roommate and staff may need follow-up per facility policy.

Cleaning versus disinfection, plainly

  • Cleaning = physical removal of soil and a large fraction of organisms. Disinfection = chemical inactivation of most pathogenic organisms on inanimate surfaces. Sterilization (destruction of all microbial life, including spores) is not required for a flow sensor and usually would destroy it. Equipment designated single-use must never be reprocessed.

The afternoon's exercise testing

  • The room and the device were both involved in a coughing episode with a multi-drug-resistant organism. Do not run exercise testing in that room until it has been cleaned per the facility's terminal-cleaning protocol - surfaces, chair, door handles, and any shared equipment.
  • Use a different device for the afternoon, and if none is available, the exercise test moves or is rescheduled. Exercise testing generates far more aerosol than quiet breathing, so an incompletely decontaminated room is a much larger exposure than the spirometry visit itself.
  • Confirm the sensor has passed verification before it returns to service, and if it does not, remove it from service and document - a sensor that fails after decontamination may have been damaged by the process, which is itself a reportable QC finding.